Figure 2.
Kaplan–Meier survival curves showing the combined (A) median progression-free (PFS) and (B) median overall survival (OS) for patients being treated with pazopanib.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.